Unknown

Dataset Information

0

?-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons.


ABSTRACT: Cognitive impairment in Alzheimer's disease (AD) patients is associated with a decline in the levels of growth factors, impairment of axonal transport and marked degeneration of basal forebrain cholinergic neurons (BFCNs). Neurogenesis persists in the adult human brain, and the stimulation of regenerative processes in the CNS is an attractive prospect for neuroreplacement therapy in neurodegenerative diseases such as AD. Currently, it is still not clear how the pathophysiological environment in the AD brain affects stem cell biology. Previous studies investigating the effects of the ?-amyloid (A?) peptide on neurogenesis have been inconclusive, since both neurogenic and neurotoxic effects on progenitor cell populations have been reported. In this study, we treated pluripotent human embryonic stem (hES) cells with nerve growth factor (NGF) as well as with fibrillar and oligomeric A?1-40 and A?1-42 (nM-µM concentrations) and thereafter studied the differentiation in vitro during 28-35 days. The process applied real time quantitative PCR, immunocytochemistry as well as functional studies of intracellular calcium signaling. Treatment with NGF promoted the differentiation into functionally mature BFCNs. In comparison to untreated cells, oligomeric A?1-40 increased the number of functional neurons, whereas oligomeric A?1-42 suppressed the number of functional neurons. Interestingly, oligomeric A? exposure did not influence the number of hES cell-derived neurons compared with untreated cells, while in contrast fibrillar A?1-40 and A?1-42 induced gliogenesis. These findings indicate that A?1-42 oligomers may impair the function of stem cell-derived neurons. We propose that it may be possible for future AD therapies to promote the maturation of functional stem cell-derived neurons by altering the brain microenvironment with trophic support and by targeting different aggregation forms of A?.

SUBMITTER: Wicklund L 

PROVIDER: S-EPMC3003688 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Β-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons.

Wicklund Linn L   Leão Richardson N RN   Strömberg Anne-Marie AM   Mousavi Malahat M   Hovatta Outi O   Nordberg Agneta A   Marutle Amelia A  

PloS one 20101217 12


Cognitive impairment in Alzheimer's disease (AD) patients is associated with a decline in the levels of growth factors, impairment of axonal transport and marked degeneration of basal forebrain cholinergic neurons (BFCNs). Neurogenesis persists in the adult human brain, and the stimulation of regenerative processes in the CNS is an attractive prospect for neuroreplacement therapy in neurodegenerative diseases such as AD. Currently, it is still not clear how the pathophysiological environment in  ...[more]

Similar Datasets

| S-EPMC3107131 | biostudies-literature
| S-EPMC3829014 | biostudies-literature
| S-EPMC3780781 | biostudies-literature
| S-EPMC3896712 | biostudies-literature
| S-EPMC4754683 | biostudies-literature
| S-EPMC2857410 | biostudies-literature
| S-EPMC6317145 | biostudies-literature
| S-EPMC3362278 | biostudies-literature
| S-EPMC4120959 | biostudies-literature
| S-EPMC4201942 | biostudies-literature